SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-13-010343
Filing Date
2013-11-07
Accepted
2013-11-06 19:06:43
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B4 a2217265z424b4.htm 424B4 1854059
2 G1009354.JPG g1009354.jpg GRAPHIC 13047
3 G318679.JPG g318679.jpg GRAPHIC 76752
4 G839017.JPG g839017.jpg GRAPHIC 101644
5 G514398.JPG g514398.jpg GRAPHIC 169734
6 G758890.JPG g758890.jpg GRAPHIC 155971
7 G645259.JPG g645259.jpg GRAPHIC 74620
  Complete submission text file 0001047469-13-010343.txt   2671162
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-191584 | Film No.: 131197909
SIC: 2834 Pharmaceutical Preparations